Ectopic Fat Accumulation in Distinct Insulin Resistant Phenotypes; Targets for Personalized Nutritional Interventions
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Cardiometabolic diseases are one of the leading causes for disability and mortality in the Western world. The prevalence of these chronic diseases is expected to rise even further in the next decades. Insulin resistance (IR) and related metabolic disturbances are linked to ectopic fat deposition, which is the storage of excess lipids in metabolic organs such as liver and muscle. Notably, a vicious circle exists between IR and ectopic fat, together increasing the risk for the development of cardiometabolic diseases. Nutrition is a key-determining factor for both IR and ectopic fat deposition. The macronutrient composition of the diet may impact metabolic processes related to ectopic fat accumulation and IR. Interestingly, however, the metabolic phenotype of an individual may determine the response to a certain diet. Therefore, population-based nutritional interventions may not always lead to the most optimal (cardiometabolic) outcomes at the individual level, and differences in the metabolic phenotype may underlie conflicting findings related to IR and ectopic fat in dietary intervention studies. Detailed metabolic phenotyping will help to better understand the complex relationship between diet and metabolic regulation, and to optimize intervention outcomes. A subgroup-based approach that integrates, among others, tissue-specific IR, cardiometabolic parameters, anthropometrics, gut microbiota, age, sex, ethnicity, and psychological factors may thereby increase the efficacy of dietary interventions. Nevertheless, the implementation of more personalized nutrition may be complex, costly, and time consuming. Future studies are urgently warranted to obtain insight into a more personalized approach to nutritional interventions, taking into account the metabolic phenotype to ultimately improve insulin sensitivity and reduce the risk for cardiometabolic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Self-citationGenetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
Kautzky-Willer, A., Harreiter, J., & Pacini, G. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1137 · Cited by 2,043
The Finnish Diabetes Prevention Study (DPS)
Lindström, J., Louheranta, A., Mannelin, M., Rastas, M., Salminen, V., Eriksson, J., Uusitupa, M., Tuomilehto, J., & for the Finnish Diabetes Prevention Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3230 · Cited by 1,848
Impaired Fasting Glucose and Impaired Glucose Tolerance
Nathan, D. M., Davidson, M. B., DeFronzo, R. A., Heine, R. J., Henry, R. R., Pratley, R., & Zinman, B. (2007) · Diabetes Care · doi:10.2337/dc07-9920 · Cited by 1,396
Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease
Shulman, G. I. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1011035 · Cited by 1,126 · cited 2×
“For example, polymorphism of the ApoC3 and PNPLA3 gene have been linked to alterations in IHCL, and are more prevalent in South-Asian and Hispanic individuals, respectively (52, 104, 105).”
BackgroundVessby, B., Uusitupa, M., Hermansen, K., Riccardi, G., Rivellese, A. A., Tapsell, L. C., Nälsén, C., Berglund, L., Louheranta, A., Rasmussen, B. M., et al. (2001) · Diabetologia · doi:10.1007/s001250051620 · Cited by 1,119 · cited 1×
“Several longer-term (12–24 weeks) large dietary intervention studies that investigated the effects of isoenergetic replacement of SFA with MUFA and/or PUFA on insulin sensitivity either did not report significant improvements in insulin sensitivity following the different diets (117, 118), or only reported significanc…”
BackgroundSex differences in human adipose tissues – the biology of pear shape
Karastergiou, K., Smith, S. R., Greenberg, A. S., & Fried, S. K. (2012) · Biology of Sex Differences · doi:10.1186/2042-6410-3-13 · Cited by 1,109 · cited 3×
“VAT has been linked to higher levels of inflammatory markers, insulin resistance and other cardiometabolic complications (83, 84).”
BackgroundAdipose tissue expandability, lipotoxicity and the Metabolic Syndrome — An allostatic perspective
Virtue, S., & Vidal-Puig, A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.12.006 · Cited by 1,013 · cited 1×
“Interestingly, the expandability of subcutaneous adipose tissue seems to be a critical factor in the development of insulin resistance (81, 82).”
BackgroundMetabolic Flexibility in Health and Disease
Goodpaster, B. H., & Sparks, L. M. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.015 · Cited by 995 · cited 1×
“As a consequence, the body is not effectively able to adapt to its metabolic or energy demands, also described as metabolic inflexibility (2, 3).”
BackgroundFatty acids, obesity, and insulin resistance: Time for a reevaluation
Karpe, F., Dickmann, J. R., & Frayn, K. N. (2011) · Diabetes · doi:10.2337/db11-0425 · Cited by 896 · cited 2×
“In fasted and postprandial IR conditions, (slightly) elevated levels of non-esterified fatty acids (NEFA), very-low-density lipoprotein (VLDL)-TAG (21), and dietary-derived chylomicronTAG (22) are observed, although data is not entirely consistent (23, 24).”
BackgroundGluteofemoral body fat as a determinant of metabolic health
Manolopoulos, K. N., Karpe, F., & Frayn, K. N. (2010) · International Journal of Obesity · doi:10.1038/ijo.2009.286 · Cited by 811
Ryan, M. C., Itsiopoulos, C., Thodis, T., Ward, G., Trost, N., Hofferberth, S., O’Dea, K., Desmond, P. V., Johnson, N. A., & Wilson, A. M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.012 · Cited by 778
Age-related changes in total and regional fat distribution
Kuk, J. L., Saunders, T. J., Davidson, L. E., & Ross, R. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.06.001 · Cited by 778 · cited 4×
“Noteworthy, for a given BMI, men generally have more muscle mass as compared to women, which may at least partly explain the latter findings (8).”
BackgroundResultInfluentialThe role of fructose in the pathogenesis of NAFLD and the metabolic syndrome
Lim, J. S., Mietus-Snyder, M., Valente, A., Schwarz, J.-M., & Lustig, R. H. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.41 · Cited by 771
The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome
Petersen, K. F., Dufour, S., Savage, D. B., Bilz, S., Solomon, G., Yonemitsu, S., Cline, G. W., Befroy, D., Zemany, L., Kahn, B. B., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705408104 · Cited by 759
Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue
Kosteli, A., Sugaru, E., Haemmerle, G., Martin, J. F., Lei, J., Zechner, R., & Ferrante, A. W. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42845 · Cited by 726 · cited 2×
“Notably, LPL in AT macrophages has been found to increase AT lipid storage in obese mice (30, 31).”
BackgroundThe distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals
Blüher, M. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283346ccc · Cited by 632
Sex differences in metabolic homeostasis, diabetes, and obesity
Mauvais-Jarvis, F. (2015) · Biology of Sex Differences · doi:10.1186/s13293-015-0033-y · Cited by 626
The role of mitochondria in insulin resistance and type 2 diabetes mellitus
Szendroedi, J., Phielix, E., & Roden, M. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.138 · Cited by 600 · cited 1×
“The decreased skeletal muscle oxidative capacity may be a result of reduced mitochondrial activity, content, and/or plasticity, leading to an imbalance between lipid supply, lipid oxidation, and conversion into TAG (50).”
BackgroundSex and gender differences in health: Science & Society Series on Sex and Science
Regitz‐Zagrosek, V. (2012) · The EMBO Reports · doi:10.1038/embor.2012.87 · Cited by 572
Assessment of insulin sensitivity/resistance
Gutch, M., Kumar, S., Razi, S., Gupta, K., & Gupta, A. (2015) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.146874 · Cited by 555 · cited 1×
“, HOMAIR, Matsuda Index, M-value) differ between studies and may reflect different etiologies of IR (131, 132).”
ResultSex Differences in Body Composition
Bredella, M. A. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-70178-3_2 · Cited by 523
Adipose tissue plasticity: how fat depots respond differently to pathophysiological cues
Pellegrinelli, V., Carobbio, S., & Vidal-Puig, A. (2016) · Diabetologia · doi:10.1007/s00125-016-3933-4 · Cited by 432 · cited 2×
“VAT has been linked to higher levels of inflammatory markers, insulin resistance and other cardiometabolic complications (83, 84).”
BackgroundApolipoprotein C3 gene variants in nonalcoholic fatty liver disease
Petersen, K. F., Dufour, S., Hariri, A., Nelson-Williams, C., Foo, J. N., Zhang, X.-M., Dziura, J., Lifton, R. P., & Shulman, G. I. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907295 · Cited by 428 · cited 1×
“For example, polymorphism of the ApoC3 and PNPLA3 gene have been linked to alterations in IHCL, and are more prevalent in South-Asian and Hispanic individuals, respectively (52, 104, 105).”
BackgroundVisceral Adiposity and the Risk of Metabolic Syndrome Across Body Mass Index
Shah, R. V., Murthy, V. L., Abbasi, S. A., Blankstein, R., Kwong, R. Y., Goldfine, A. B., Jerosch-Herold, M., Lima, J. A. C., Ding, J., & Allison, M. A. (2014) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2014.07.017 · Cited by 427 · cited 8×
“These metabolic differences in adipose tissue depots may partially explain why women are relatively protected against metabolic diseases compared to men with the same BMI (84).”
BackgroundInfluentialIncreased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance
Choi, S. H., & Ginsberg, H. N. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.04.007 · Cited by 418 · cited 1×
“In fasted and postprandial IR conditions, (slightly) elevated levels of non-esterified fatty acids (NEFA), very-low-density lipoprotein (VLDL)-TAG (21), and dietary-derived chylomicronTAG (22) are observed, although data is not entirely consistent (23, 24).”
BackgroundIncreased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men
Petersen, K. F., Dufour, S., Feng, J., Befroy, D., Dziura, J., Man, C. D., Cobelli, C., & Shulman, G. I. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608537103 · Cited by 403
Roles of diacylglycerols and ceramides in hepatic insulin resistance
Petersen, M. C., & Shulman, G. I. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.04.004 · Cited by 373
Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions.
Snel, M., Jonker, J. T., Schoones, J., Lamb, H., de Roos, A., Pijl, H., Smit, J. W. A., Meinders, A. E., & Jazet, I. M. (2012) · International Journal of Endocrinology · doi:10.1155/2012/983814 · Cited by 368 · cited 8×
“Diet and physical activity are key modifiable risk factors that play a significant role in the development, progression and reversal of IR and ectopic fat accumulation (5, 10).”
BackgroundInfluentialDownregulation of Adipose Tissue Fatty Acid Trafficking in Obesity
McQuaid, S. E., Hodson, L., Neville, M. J., Dennis, A. L., Cheeseman, J., Humphreys, S. M., Ruge, T., Gilbert, M., Fielding, B. A., Frayn, K. N., et al. (2011) · Diabetes · doi:10.2337/db10-0867 · Cited by 366
Sniderman, A. D., Bhopal, R., Prabhakaran, D., Sarrafzadegan, N., & Tchernof, A. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dyl245 · Cited by 343 · cited 1×
“A possible explanation for this could be that SouthAsians have a decreased lipid storage capacity in subcutaneous adipose tissue, leading to an excess flux of lipids toward other tissues such as visceral adipose tissue, the liver, pancreas, heart, and skeletal muscle (102).”
BackgroundSkeletal muscle fat oxidation: Timing and flexibility are everything
Kelley, D. E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25758 · Cited by 298 · cited 1×
“The high oxidative capacity represents the ability of the body to adapt to the appropriate metabolic condition, also described as metabolic flexibility (46).”
BackgroundMitochondrial dysfunction and lipotoxicity
Schrauwen, P., Schrauwen-Hinderling, V., Hoeks, J., & Hesselink, M. K. C. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.011 · Cited by 268
Liver ATP Synthesis Is Lower and Relates to Insulin Sensitivity in Patients With Type 2 Diabetes
Schmid, A. I., Szendroedi, J., Chmelik, M., Krššák, M., Moser, E., & Roden, M. (2011) · Diabetes Care · doi:10.2337/dc10-1076 · Cited by 212
Jebb, S. A., Lovegrove, J. A., Griffin, B. A., Frost, G. S., Moore, C. S., Chatfield, M. D., Bluck, L. J., Williams, C. M., & Sanders, T. A. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.29096 · Cited by 192 · cited 1×
“Several longer-term (12–24 weeks) large dietary intervention studies that investigated the effects of isoenergetic replacement of SFA with MUFA and/or PUFA on insulin sensitivity either did not report significant improvements in insulin sensitivity following the different diets (117, 118), or only reported significanc…”
BackgroundTargeting fatty acid metabolism to improve glucose metabolism
Stinkens, R., Goossens, G. H., Jocken, J. W. E., & Blaak, E. E. (2015) · Obesity Reviews · doi:10.1111/obr.12298 · Cited by 183 · cited 20×
“However, irrespective of the relationship between liver and skeletal muscle fat accumulation and liver- and muscle-IR, both IHCL and IMCL seem to play an important role in the progression toward T2DM (2).”
BackgroundInfluentialSelf-citationDeterminants of intramyocellular triglyceride turnover: implications for insulin sensitivity
Moro, C., Bajpeyi, S., & Smith, S. R. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00624.2007 · Cited by 179
Yip, W., Sequeira, I., Plank, L., & Poppitt, S. (2017) · Nutrients · doi:10.3390/nu9111273 · Cited by 177
Anand, S. S., Tarnopolsky, M. A., Rashid, S., Schulze, K. M., Desai, D., Mente, A., Rao, S., Yusuf, S., Gerstein, H. C., & Sharma, A. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022112 · Cited by 174
Perseghin, G., Scifo, P., Pagliato, E., Battezzati, A., Benedini, S., Soldini, L., Testolin, G., Del Maschio, A., & Luzi, L. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7666 · Cited by 112
Impaired skeletal muscle substrate oxidation in glucose-intolerant men improves after weight loss
Corpeleijn, E., Mensink, M., Kooi, M. E., Roekaerts, P. M. H. J., Saris, W. H. M., & Blaak, E. E. (2008) · Obesity · doi:10.1038/oby.2008.24 · Cited by 104 · cited 1×
“These disturbances reflect, at least partly, a decreased capacity of the skeletal muscle to oxidize lipids (48) and a decreased ability to switch from carbohydrate to fat oxidation (49).”
BackgroundSelf-citationBravo, S., Lowndes, J., Sinnett, S., Yu, Z., & Rippe, J. (2013) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2012-0322 · Cited by 86 · cited 1×
“Furthermore, another study measured fat content in liver or skeletal muscle by computed tomography (CT) and found no differences between a 10-week isocaloric diet high in fructose and an isocaloric diet high in sucrose (123).”
BackgroundUtzschneider, K. M., Bayer-Carter, J. L., Arbuckle, M. D., Tidwell, J. M., Richards, T. L., & Craft, S. (2013) · British Journal of Nutrition · doi:10.1017/s0007114512002966 · Cited by 81 · cited 1×
“Indeed, an isocaloric low-GI diet for 4 weeks in overweight older adults led to a significant decrease in IHCL and improvement in insulin sensitivity (Matsuda index) compared to a 4-week isocaloric high-GI diet (121) (Table 1).”
MethodLê, K.-A., & Bortolotti, M. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328302f3ec · Cited by 60 · cited 2×
“A diet low in glycemic index (GI), which is a relative ranking of foods and their effect on blood glucose values, may therefore be beneficial in relation to insulin sensitivity, and has also been linked to decreased IHCL accumulation (120).”
BackgroundFructose metabolism and noncommunicable diseases: recent findings and new research perspectives
Tappy, L. (2018) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000460 · Cited by 37
Cited by
Fassarella, M., Blaak, E. E., Penders, J., Nauta, A., Smidt, H., & Zoetendal, E. G. (2021) · Gut · doi:10.1136/gutjnl-2020-321747 · Cited by 772
Self-citationGuo, J., Givens, D. I., Astrup, A., Bakker, S. J. L., Goossens, G. H., Kratz, M., Marette, A., Pijl, H., & Soedamah‐Muthu, S. S. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz050 · Cited by 69
Self-citationInflammation and metabolism: the role of adiposity in sarcopenic obesity
Lynch, G. M., Murphy, C. H., Castro, E. D. M., & Roche, H. M. (2020) · Proceedings of the Nutrition Society · doi:10.1017/s0029665120007119 · Cited by 41
“skeletal IR((183)), wherein different interventions may be appropriate((184)).”
BackgroundTrouwborst, I., Goossens, G. H., Astrup, A., Saris, W. H. M., & Blaak, E. E. (2021) · Nutrients · doi:10.3390/nu13051588 · Cited by 31
Self-citation
Metadata
- Authors
- Trouwborst, I., Bowser, S. M., Goossens, G. H., & Blaak, E. E.
- Venue
- Frontiers in Nutrition
- Publisher
- Frontiers Media SA
- Published
- 2018-09-04
- Volume
- 5
- Pages
- 77-77
- ISSN
- 2296-861X (ISSN-L)
- OpenAlex
- W2890552659
- Cited by
- 111
- References
- 47
- FWCI
- 6.31
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.